A cell transmembrane peptide chimeric M(27–39)-HTPP targeted therapy for hepatocellular carcinoma

Jibin Wu, Rui Deng, Jianling Yan, Baokang Zhu, Jian Wang, Yinghua Xu, Shuiqing Gui, Xiaobao Jin, Xuemei Lu

Open source

DOI
10.1016/j.isci.2023.106766
Published
2023-05
Container
iScience
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.isci.2023.106766,
  title = {A cell transmembrane peptide chimeric M(27–39)-HTPP targeted therapy for hepatocellular carcinoma},
  author = {Jibin Wu and Rui Deng and Jianling Yan and Baokang Zhu and Jian Wang and Yinghua Xu and Shuiqing Gui and Xiaobao Jin and Xuemei Lu},
  year = {2023},
  journal = {iScience},
  doi = {10.1016/j.isci.2023.106766},
  url = {https://doi.org/10.1016/j.isci.2023.106766}
}

RIS

TY  - JOUR
TI  - A cell transmembrane peptide chimeric M(27–39)-HTPP targeted therapy for hepatocellular carcinoma
AU  - Jibin Wu
AU  - Rui Deng
AU  - Jianling Yan
AU  - Baokang Zhu
AU  - Jian Wang
AU  - Yinghua Xu
AU  - Shuiqing Gui
AU  - Xiaobao Jin
AU  - Xuemei Lu
PY  - 2023
JO  - iScience
DO  - 10.1016/j.isci.2023.106766
UR  - https://doi.org/10.1016/j.isci.2023.106766
ER  - 

APA

Wu, J., Deng, R., Yan, J., Zhu, B., Wang, J., Xu, Y., Gui, S., Jin, X., & Lu, X. (2023). A cell transmembrane peptide chimeric M(27–39)-HTPP targeted therapy for hepatocellular carcinoma. iScience. https://doi.org/10.1016/j.isci.2023.106766

Source records